Peripheral Blood Mononuclear Cells (PBMCs) are key immune cells separate from peripheral blood and crucial to the immune response ... qPCR, next-generation sequencing, and flow cytometry.

While capable of driving a powerful anti-tumor response, these cells often remain inactive, limiting the immune system's response to the tumor. The stem-like CD4 T cells have the ability to renew ...

ImCheck to Present Updated Data from the EVICTION Trial at the 39 th Annual Meeting of the Society for Immunotherapy of Cancer ...

The confirmed overall response rate (ORR) was 42.1% ... Alligator also had a poster presentation on ATOR-4066, its ...

Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated cell therapies for the treatment of cancer and autoimmune diseases, today ...

Antibody proteomics advances vaccine research, revealing immune responses and identifying proteins essential for developing effective vaccines against diseases.

Their markers are the target of researchers to open new therapeutic pathways. One of the challenges pursued by HIV researchers is to understand how and why some people manage to deal with the ...